Is it safe to eat curry or golden milk while I''m on warfarin?

Yes. Culinary use of turmeric — roughly 1–3 grams of dried root per day, which is what ends up in curry, dal, golden milk, or turmeric tea — has never been shown to destabilise warfarin in clinical practice. The interaction is with concentrated curcumin extracts (capsules of 500 mg curcuminoids or Meriva/piperine-enhanced formulas), not food. Keep cooking; just don''t add a supplement capsule on top without telling your prescriber.

I take apixaban (Eliquis). My INR is always fine. Doesn''t that mean curcumin is safe for me?

No, and this is a dangerous assumption. Apixaban and the other DOACs (rivaroxaban, edoxaban, dabigatran) are not monitored by INR. INR reflects warfarin''s effect, not DOAC blood levels. Curcumin extracts inhibit CYP3A4 and P-glycoprotein, which raise DOAC concentrations — silently. The first sign is usually a bleed (bruising, nosebleeds, GI bleed), not a lab result. Please do not use a normal INR as reassurance on a DOAC.

How long before surgery should I stop my curcumin supplement?

For elective surgery, stop at least 14 days beforehand and tell the anaesthetist and surgeon what you were taking, at what dose, and with what absorption enhancer (piperine, Meriva, liposomal, etc). For minor dental work, 7 days is usually enough; for major dental (multiple extractions, implants) or colonoscopy with anticipated biopsy, 10–14 days. Curcumin''s antiplatelet effect washes out as new platelets are produced (~7–10 days), and its enzyme-inhibition effect clears in days once the supplement stops.

What about turmeric + aspirin 81 mg for cardiovascular protection? My doctor said aspirin was fine.

Low-dose aspirin was cleared by your cardiologist as a single antiplatelet agent. Adding a high-dose curcumin extract turns that into de facto dual antiplatelet therapy without the cardiologist''s knowledge. That is the problem — not the aspirin, not the curcumin individually, but the stack. Watch for bruising, nosebleeds, and gum bleeding, and disclose the supplement at your next cardiology visit. Culinary turmeric in food does not raise this concern.

My supplement label says ''500 mg turmeric'' — is that a low dose or a high dose?

That label is close to useless without two more pieces of information: (1) the curcuminoid percentage (plain turmeric root is ~2–5% curcuminoids, while ''95% standardised extract'' is 20× more concentrated per mg), and (2) whether an absorption enhancer is included (piperine boosts curcumin bioavailability ~20-fold, Meriva phytosome ~29-fold). A ''500 mg'' capsule of 95% curcuminoids with piperine can deliver more systemic curcumin than 10 grams of plain root. If the label doesn''t tell you percentage and enhancer, treat it as a high-dose extract, not a spice.

Turmeric and Blood Thinners: Curcumin Bleeding Risk, Dose Tiers, and Safer Use

Quick answer

Turmeric used as a cooking spice (1–3 g of dried root in curry, dal, or golden milk) has not been linked to clinically meaningful bleeding, even in patients on warfarin or direct oral anticoagulants (DOACs). The problem is concentrated curcumin extracts — the capsules sold as "high absorption," "95% curcuminoids," or paired with piperine, phytosome (Meriva), or nano/liposomal delivery.

At extract doses of 500 mg/day curcuminoids and above, curcumin has measurable antiplatelet activity and inhibits several drug-metabolising enzymes (CYP3A4, CYP2C9, CYP1A2) plus the P-glycoprotein efflux pump. Combined with warfarin, apixaban, rivaroxaban, dabigatran, aspirin, or clopidogrel, this can push INR up, raise DOAC blood levels, and cause bruising, nosebleeds, gum bleeding, prolonged menstrual bleeding, or — in published case reports — GI and intracranial haemorrhage.

If you are on any anticoagulant or antiplatelet drug, treat curcumin extracts the same way you would treat a second blood thinner: do not start one without your prescriber knowing, and stop it at least 1–2 weeks before surgery, dental extractions, or colonoscopy with biopsy.

How curcumin actually thins the blood

Curcumin — the main active polyphenol in turmeric — is a poor drug on paper. Native curcumin has extremely low oral bioavailability: less than 1% of a swallowed dose reaches systemic circulation without help. That is exactly why the supplement industry engineered around it. Piperine (from black pepper) blocks curcumin''s glucuronidation and boosts plasma levels ~20-fold. Phytosome complexes (Meriva) increase absorption ~29-fold. Nano and liposomal formulas push it further. What used to be a food polyphenol is now, in extract form, a systemic drug.

Once absorbed, curcumin acts on the clotting cascade at three levels:

1. Platelet aggregation. Curcumin inhibits arachidonic acid–, ADP–, collagen–, and thrombin-induced platelet aggregation in a dose-dependent manner. The mechanism overlaps aspirin''s — suppression of thromboxane A2 synthesis via COX-1 — but also includes inhibition of platelet PAF (platelet-activating factor) signalling. Stacking curcumin with aspirin or clopidogrel is not additive of two mild agents; it is two antiplatelet drugs hitting the same platelet.

2. Coagulation factors. In vitro and animal studies show curcumin prolongs prothrombin time (PT) and activated partial thromboplastin time (aPTT), consistent with interference at both the extrinsic and intrinsic pathways. Clinical relevance is modest at spice doses, but rises with extract concentration.

3. Drug-metabolising enzymes and transporters. This is the underappreciated route. Curcumin inhibits CYP3A4, CYP2C9, CYP1A2, and P-glycoprotein. Warfarin is a CYP2C9 substrate; the S-warfarin enantiomer (five times more potent than R-warfarin) is metabolised almost entirely by CYP2C9. Inhibit CYP2C9 and warfarin plasma levels — and therefore INR — climb. Apixaban and rivaroxaban are CYP3A4 + P-gp substrates. Inhibit both pathways and DOAC blood levels rise, without any change in the INR (DOACs are not monitored by INR, so the bleeding risk stays invisible until it bleeds).

This dual mechanism — direct antiplatelet effect plus interference with anticoagulant metabolism — is why the interaction is not theoretical. It is documented.

What the case reports actually show

The clearest signal comes from published case series and pharmacovigilance databases, not from large randomized trials (which have never been ethically feasible in patients on chronic anticoagulation).

Warfarin + curcumin extract cases: multiple published reports describe stable warfarin patients whose INR rose from a therapeutic 2.0–3.0 range to 5.0–8.0+ within 2–4 weeks of starting a curcumin extract, with resolution after stopping the supplement and no other dietary or drug change.
DOAC cases: post-market surveillance reports include GI bleeds and haematomas in patients combining apixaban or rivaroxaban with high-dose curcumin, particularly Meriva or piperine-enhanced formulas.
Perioperative bleeds: unexpected intraoperative bleeding in patients who did not disclose their turmeric supplement to the anaesthetist, but who were taking 1,000+ mg/day of a curcuminoid extract.

None of this appears in patients who eat curry three times a week. All of it appears in patients taking capsules.

Dose tiers: where the line actually sits

There is no crisp regulatory threshold, but the clinical literature and EFSA''s ADI (Acceptable Daily Intake of 3 mg curcumin per kg body weight — ~180 mg for a 60 kg adult) let us stratify realistically.

| Tier | Curcuminoid intake | Typical source | Risk on anticoagulants / antiplatelets | | --- | --- | --- | --- | | Culinary | ~15–100 mg/day curcuminoids (from 1–3 g dried turmeric) | Curry, dal, golden milk, turmeric tea | Not clinically significant. Continue normally. | | Low-dose supplement | 100–500 mg/day curcuminoids | Plain turmeric capsules without absorption enhancers | Low but non-zero. Disclose to prescriber; watch for bruising. | | Enhanced-absorption | 200–500 mg/day of Meriva, BCM-95, piperine-boosted, nano/liposomal | Joint / inflammation / gut formulas | Systemic exposure comparable to 1–2 g plain extract. Treat as high-dose. | | High-dose extract | 500–2,000 mg/day curcuminoids | "Standardised 95%" extracts, arthritis / anti-cancer dosing regimens | Meaningful antiplatelet + CYP2C9 / CYP3A4 inhibition. Do not stack with warfarin, DOACs, aspirin, or P2Y12 inhibitors without medical supervision. |

The dominant mistake we see in the Glowbit intake data is people counting "one capsule per day" as low dose, without checking that the capsule is Meriva 500 mg — bioequivalent to well over a gram of plain extract.

Specific drug pairings

Warfarin (Coumadin). The clearest interaction. Curcumin extracts inhibit CYP2C9 and add antiplatelet effect on top of anticoagulation. If a patient on stable warfarin starts a curcumin extract, expect INR drift upward over 1–3 weeks. Any new curcumin extract should trigger an INR check within 5–7 days and again at 2 weeks. Never adjust warfarin dose to "make room" for a supplement — deprescribe the supplement.

Apixaban (Eliquis), rivaroxaban (Xarelto), edoxaban (Lixiana). CYP3A4 + P-gp substrates. Curcumin at extract doses inhibits both. Because DOACs are not INR-monitored, the risk is silent. Symptoms first — bruising, nosebleeds, prolonged menstrual bleeding, dark stools — and by then a bleed may already be underway.

Dabigatran (Pradaxa). Primarily P-gp dependent (not CYP-metabolised). Curcumin''s P-gp inhibition is the relevant lever. Effect is likely smaller than with apixaban/rivaroxaban but not zero.

Aspirin (any dose). Additive antiplatelet effect. Low-dose aspirin 81 mg + high-dose curcumin extract is functionally dual antiplatelet therapy without the cardiologist knowing.

Clopidogrel (Plavix), ticagrelor (Brilinta), prasugrel (Effient). Additive antiplatelet effect. Also, clopidogrel requires CYP2C19 activation — this is not curcumin''s main target, so the risk here is primarily additive antiplatelet action rather than metabolic.

Heparin / LMWH (enoxaparin, dalteparin). Short-term perioperative or DVT-treatment use. Additive risk; avoid extract dosing during any heparin/LMWH course.

Warning signs that mean stop and call

Any of the following, in a patient combining curcumin extract with an anticoagulant or antiplatelet drug, is a "stop the supplement today and contact your prescriber" event:

New or spontaneous bruising, especially in areas without obvious trauma
Nosebleeds lasting more than 10 minutes, or recurring more than twice a week
Bleeding gums when brushing that did not happen before
Prolonged or unusually heavy menstrual bleeding
Blood in urine (pink, red, or tea-coloured) or stools (bright red, or black and tarry)
Persistent headache, especially with dizziness, weakness, or vision changes — this can indicate intracranial bleeding and is a call emergency services event, not a "wait and see"

An INR result above your therapeutic range on a stable warfarin regimen, with no other explanation, should prompt a supplement review as one of the first questions.

Surgery, dental work, colonoscopy

Curcumin''s antiplatelet effect washes out over roughly a week as new platelets are produced (platelet lifespan ~7–10 days). Its enzyme-inhibition effect resolves faster (days) once curcumin is cleared. A reasonable, conservative rule for elective procedures:

Minor dental (cleaning, single extraction): stop curcumin extract 7 days before
Major dental (multiple extractions, implants): stop 10–14 days before
Elective surgery: stop 14 days before, disclose to anaesthetist and surgeon
Colonoscopy with anticipated biopsy or polypectomy: stop 7–14 days before, aligned with your gastroenterologist''s instructions on other antiplatelets

Emergency surgery in a patient recently taking high-dose curcumin should be flagged to the surgical team; there is no specific reversal agent, but knowing the risk changes intraoperative haemostasis planning.

Safer alternatives if you actually want the anti-inflammatory effect

The reason people take turmeric is almost always joint pain, gut inflammation, or general "anti-inflammatory" hope. If you are on a blood thinner and want to keep some of that benefit without stacking bleeding risk:

Culinary turmeric: continue using it in food freely. No signal for interaction at food doses.
Omega-3 fish oil at low doses (<3 g/day EPA+DHA): has its own considerations on anticoagulants (see our dedicated article), but at low doses is generally better characterised than curcumin extracts.
Topical NSAID gels (diclofenac gel): for joint pain, systemic absorption is minimal — often a safer option than any oral anti-inflammatory in an anticoagulated patient.
Physical therapy, weight management, sleep: unglamorous, but the systemic inflammation reductions are real and don''t touch platelets.

"Just take a lower dose of curcumin" is not a safe alternative — the enhanced-absorption formulas mean dose on the label ≠ dose in the blood.

How Glowbit handles this

Glowbit does not treat turmeric as a single ingredient. Behind the scenes:

The ingredient graph distinguishes turmeric root powder (culinary-tier exposure) from curcuminoid extract and further from enhanced-absorption formulations (Meriva, BCM-95, phytosome, piperine-added, liposomal, nano). A 500 mg Meriva capsule is scored at a much higher effective curcumin exposure than 500 mg of plain turmeric powder — because it is.
Any supplement product tagged as a curcumin extract triggers an interaction scan against your active prescription list. If you have warfarin, apixaban, rivaroxaban, edoxaban, dabigatran, aspirin, clopidogrel, ticagrelor, prasugrel, enoxaparin, or dalteparin logged, the app surfaces the interaction on the Today screen — before you take the dose, not after.
The alert is intentionally about the supplement, not the drug. Glowbit will not tell you to change your warfarin dose or skip your DOAC. It will tell you the curcumin extract is a poor pairing and recommend a conversation with your prescriber or pharmacist.
Culinary use of turmeric in food is not flagged. The goal is safety, not paranoia.

> Physician''s note (Rx-redline). This article is informational. If you are on any anticoagulant or antiplatelet medication, do not start, stop, or change your prescription based on what you read here. Any decision about warfarin, DOACs, aspirin, clopidogrel, or heparin belongs to your prescribing physician or pharmacist. Glowbit''s role — and this article''s role — is to help you notice and disclose the supplement side of the equation.

Sources

EFSA Panel on Food Additives. *Refined exposure assessment for curcumin (E 100).* EFSA Journal, 2014.
NIH Office of Dietary Supplements. *Turmeric and Curcumin fact sheet.* National Institutes of Health, updated 2024.
Daveluy A. et al. *Drug interactions with curcumin: a review of the clinical evidence.* Fundamental & Clinical Pharmacology, 2021.
Bahramsoltani R. et al. *Pharmacokinetic interactions of curcuminoids with conventional drugs: a review.* Journal of Ethnopharmacology, 2017.
Volak L.P. et al. *Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes.* Drug Metabolism and Disposition, 2008.
Sood A. et al. *Effect of Curcuma longa on platelet aggregation and coagulation.* Various clinical observations, cited in NCCIH Herbs at a Glance: Turmeric.

Frequently Asked

Questions readers ask about this

Is it safe to eat curry or golden milk while I''m on warfarin?: Yes. Culinary use of turmeric — roughly 1–3 grams of dried root per day, which is what ends up in curry, dal, golden milk, or turmeric tea — has never been shown to destabilise warfarin in clinical practice. The interaction is with concentrated curcumin extracts (capsules of 500 mg curcuminoids or Meriva/piperine-enhanced formulas), not food. Keep cooking; just don''t add a supplement capsule on top without telling your prescriber.
I take apixaban (Eliquis). My INR is always fine. Doesn''t that mean curcumin is safe for me?: No, and this is a dangerous assumption. Apixaban and the other DOACs (rivaroxaban, edoxaban, dabigatran) are not monitored by INR. INR reflects warfarin''s effect, not DOAC blood levels. Curcumin extracts inhibit CYP3A4 and P-glycoprotein, which raise DOAC concentrations — silently. The first sign is usually a bleed (bruising, nosebleeds, GI bleed), not a lab result. Please do not use a normal INR as reassurance on a DOAC.
How long before surgery should I stop my curcumin supplement?: For elective surgery, stop at least 14 days beforehand and tell the anaesthetist and surgeon what you were taking, at what dose, and with what absorption enhancer (piperine, Meriva, liposomal, etc). For minor dental work, 7 days is usually enough; for major dental (multiple extractions, implants) or colonoscopy with anticipated biopsy, 10–14 days. Curcumin''s antiplatelet effect washes out as new platelets are produced (~7–10 days), and its enzyme-inhibition effect clears in days once the supplement stops.
What about turmeric + aspirin 81 mg for cardiovascular protection? My doctor said aspirin was fine.: Low-dose aspirin was cleared by your cardiologist as a single antiplatelet agent. Adding a high-dose curcumin extract turns that into de facto dual antiplatelet therapy without the cardiologist''s knowledge. That is the problem — not the aspirin, not the curcumin individually, but the stack. Watch for bruising, nosebleeds, and gum bleeding, and disclose the supplement at your next cardiology visit. Culinary turmeric in food does not raise this concern.
My supplement label says ''500 mg turmeric'' — is that a low dose or a high dose?: That label is close to useless without two more pieces of information: (1) the curcuminoid percentage (plain turmeric root is ~2–5% curcuminoids, while ''95% standardised extract'' is 20× more concentrated per mg), and (2) whether an absorption enhancer is included (piperine boosts curcumin bioavailability ~20-fold, Meriva phytosome ~29-fold). A ''500 mg'' capsule of 95% curcuminoids with piperine can deliver more systemic curcumin than 10 grams of plain root. If the label doesn''t tell you percentage and enhancer, treat it as a high-dose extract, not a spice.